Medical Care
Global Hematologic Malignancies Detection Market Research Report 2025
- May 05, 25
- ID: 228376
- Pages: 90
- Figures: 87
- Views: 11
The global market for Hematologic Malignancies Detection was valued at US$ 2897 million in the year 2024 and is projected to reach a revised size of US$ 7426 million by 2031, growing at a CAGR of 14.6% during the forecast period.
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.
Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.
This report aims to provide a comprehensive presentation of the global market for Hematologic Malignancies Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematologic Malignancies Detection.
The Hematologic Malignancies Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hematologic Malignancies Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematologic Malignancies Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics
Segment by Type
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others
Segment by Application
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematologic Malignancies Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.
Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.
This report aims to provide a comprehensive presentation of the global market for Hematologic Malignancies Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematologic Malignancies Detection.
The Hematologic Malignancies Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hematologic Malignancies Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematologic Malignancies Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics
Segment by Type
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others
Segment by Application
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematologic Malignancies Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction
1.2.3 Immunochemistry
1.2.4 Next Generation Sequencing
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Multiple Myeloma
1.3.3 Myelodysplastic Syndrome
1.3.4 Leukemia
1.3.5 Myeloproliferative Neoplasms
1.3.6 Lymphoma
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematologic Malignancies Detection Market Perspective (2020-2031)
2.2 Global Hematologic Malignancies Detection Growth Trends by Region
2.2.1 Global Hematologic Malignancies Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hematologic Malignancies Detection Historic Market Size by Region (2020-2025)
2.2.3 Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031)
2.3 Hematologic Malignancies Detection Market Dynamics
2.3.1 Hematologic Malignancies Detection Industry Trends
2.3.2 Hematologic Malignancies Detection Market Drivers
2.3.3 Hematologic Malignancies Detection Market Challenges
2.3.4 Hematologic Malignancies Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematologic Malignancies Detection Players by Revenue
3.1.1 Global Top Hematologic Malignancies Detection Players by Revenue (2020-2025)
3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Players (2020-2025)
3.2 Global Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hematologic Malignancies Detection Revenue
3.4 Global Hematologic Malignancies Detection Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Detection Revenue in 2024
3.5 Global Key Players of Hematologic Malignancies Detection Head office and Area Served
3.6 Global Key Players of Hematologic Malignancies Detection, Product and Application
3.7 Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematologic Malignancies Detection Breakdown Data by Type
4.1 Global Hematologic Malignancies Detection Historic Market Size by Type (2020-2025)
4.2 Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031)
5 Hematologic Malignancies Detection Breakdown Data by Application
5.1 Global Hematologic Malignancies Detection Historic Market Size by Application (2020-2025)
5.2 Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hematologic Malignancies Detection Market Size (2020-2031)
6.2 North America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hematologic Malignancies Detection Market Size by Country (2020-2025)
6.4 North America Hematologic Malignancies Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematologic Malignancies Detection Market Size (2020-2031)
7.2 Europe Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hematologic Malignancies Detection Market Size by Country (2020-2025)
7.4 Europe Hematologic Malignancies Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematologic Malignancies Detection Market Size (2020-2031)
8.2 Asia-Pacific Hematologic Malignancies Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematologic Malignancies Detection Market Size (2020-2031)
9.2 Latin America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025)
9.4 Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematologic Malignancies Detection Market Size (2020-2031)
10.2 Middle East & Africa Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ArcherDx
11.1.1 ArcherDx Company Details
11.1.2 ArcherDx Business Overview
11.1.3 ArcherDx Hematologic Malignancies Detection Introduction
11.1.4 ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.1.5 ArcherDx Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 sysmex
11.3.1 sysmex Company Details
11.3.2 sysmex Business Overview
11.3.3 sysmex Hematologic Malignancies Detection Introduction
11.3.4 sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.3.5 sysmex Recent Development
11.4 Invitae
11.4.1 Invitae Company Details
11.4.2 Invitae Business Overview
11.4.3 Invitae Hematologic Malignancies Detection Introduction
11.4.4 Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.4.5 Invitae Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Details
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Hematologic Malignancies Detection Introduction
11.6.4 Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Details
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Hematologic Malignancies Detection Introduction
11.7.4 Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.7.5 Cancer Genetics Recent Development
11.8 Adaptive Biotechnologies Corporation
11.8.1 Adaptive Biotechnologies Corporation Company Details
11.8.2 Adaptive Biotechnologies Corporation Business Overview
11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Introduction
11.8.4 Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.8.5 Adaptive Biotechnologies Corporation Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Details
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hematologic Malignancies Detection Introduction
11.9.4 Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.9.5 Asuragen Recent Development
11.10 Invivoscribe
11.10.1 Invivoscribe Company Details
11.10.2 Invivoscribe Business Overview
11.10.3 Invivoscribe Hematologic Malignancies Detection Introduction
11.10.4 Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.10.5 Invivoscribe Recent Development
11.11 Nanjing Shihejiyin Technology
11.11.1 Nanjing Shihejiyin Technology Company Details
11.11.2 Nanjing Shihejiyin Technology Business Overview
11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Introduction
11.11.4 Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.11.5 Nanjing Shihejiyin Technology Recent Development
11.12 Annaroad Gene Technology
11.12.1 Annaroad Gene Technology Company Details
11.12.2 Annaroad Gene Technology Business Overview
11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Introduction
11.12.4 Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.12.5 Annaroad Gene Technology Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Details
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Hematologic Malignancies Detection Introduction
11.13.4 BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.13.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction
1.2.3 Immunochemistry
1.2.4 Next Generation Sequencing
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Multiple Myeloma
1.3.3 Myelodysplastic Syndrome
1.3.4 Leukemia
1.3.5 Myeloproliferative Neoplasms
1.3.6 Lymphoma
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematologic Malignancies Detection Market Perspective (2020-2031)
2.2 Global Hematologic Malignancies Detection Growth Trends by Region
2.2.1 Global Hematologic Malignancies Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hematologic Malignancies Detection Historic Market Size by Region (2020-2025)
2.2.3 Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031)
2.3 Hematologic Malignancies Detection Market Dynamics
2.3.1 Hematologic Malignancies Detection Industry Trends
2.3.2 Hematologic Malignancies Detection Market Drivers
2.3.3 Hematologic Malignancies Detection Market Challenges
2.3.4 Hematologic Malignancies Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematologic Malignancies Detection Players by Revenue
3.1.1 Global Top Hematologic Malignancies Detection Players by Revenue (2020-2025)
3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Players (2020-2025)
3.2 Global Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hematologic Malignancies Detection Revenue
3.4 Global Hematologic Malignancies Detection Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Detection Revenue in 2024
3.5 Global Key Players of Hematologic Malignancies Detection Head office and Area Served
3.6 Global Key Players of Hematologic Malignancies Detection, Product and Application
3.7 Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematologic Malignancies Detection Breakdown Data by Type
4.1 Global Hematologic Malignancies Detection Historic Market Size by Type (2020-2025)
4.2 Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031)
5 Hematologic Malignancies Detection Breakdown Data by Application
5.1 Global Hematologic Malignancies Detection Historic Market Size by Application (2020-2025)
5.2 Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hematologic Malignancies Detection Market Size (2020-2031)
6.2 North America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hematologic Malignancies Detection Market Size by Country (2020-2025)
6.4 North America Hematologic Malignancies Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematologic Malignancies Detection Market Size (2020-2031)
7.2 Europe Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hematologic Malignancies Detection Market Size by Country (2020-2025)
7.4 Europe Hematologic Malignancies Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematologic Malignancies Detection Market Size (2020-2031)
8.2 Asia-Pacific Hematologic Malignancies Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematologic Malignancies Detection Market Size (2020-2031)
9.2 Latin America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025)
9.4 Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematologic Malignancies Detection Market Size (2020-2031)
10.2 Middle East & Africa Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ArcherDx
11.1.1 ArcherDx Company Details
11.1.2 ArcherDx Business Overview
11.1.3 ArcherDx Hematologic Malignancies Detection Introduction
11.1.4 ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.1.5 ArcherDx Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 sysmex
11.3.1 sysmex Company Details
11.3.2 sysmex Business Overview
11.3.3 sysmex Hematologic Malignancies Detection Introduction
11.3.4 sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.3.5 sysmex Recent Development
11.4 Invitae
11.4.1 Invitae Company Details
11.4.2 Invitae Business Overview
11.4.3 Invitae Hematologic Malignancies Detection Introduction
11.4.4 Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.4.5 Invitae Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Details
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Hematologic Malignancies Detection Introduction
11.6.4 Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Details
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Hematologic Malignancies Detection Introduction
11.7.4 Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.7.5 Cancer Genetics Recent Development
11.8 Adaptive Biotechnologies Corporation
11.8.1 Adaptive Biotechnologies Corporation Company Details
11.8.2 Adaptive Biotechnologies Corporation Business Overview
11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Introduction
11.8.4 Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.8.5 Adaptive Biotechnologies Corporation Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Details
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hematologic Malignancies Detection Introduction
11.9.4 Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.9.5 Asuragen Recent Development
11.10 Invivoscribe
11.10.1 Invivoscribe Company Details
11.10.2 Invivoscribe Business Overview
11.10.3 Invivoscribe Hematologic Malignancies Detection Introduction
11.10.4 Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.10.5 Invivoscribe Recent Development
11.11 Nanjing Shihejiyin Technology
11.11.1 Nanjing Shihejiyin Technology Company Details
11.11.2 Nanjing Shihejiyin Technology Business Overview
11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Introduction
11.11.4 Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.11.5 Nanjing Shihejiyin Technology Recent Development
11.12 Annaroad Gene Technology
11.12.1 Annaroad Gene Technology Company Details
11.12.2 Annaroad Gene Technology Business Overview
11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Introduction
11.12.4 Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.12.5 Annaroad Gene Technology Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Details
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Hematologic Malignancies Detection Introduction
11.13.4 BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025)
11.13.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hematologic Malignancies Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Immunochemistry
Table 4. Key Players of Next Generation Sequencing
Table 5. Key Players of Fluorescence in Situ Hybridization
Table 6. Key Players of Others
Table 7. Global Hematologic Malignancies Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Hematologic Malignancies Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Hematologic Malignancies Detection Market Share by Region (2020-2025)
Table 11. Global Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Hematologic Malignancies Detection Market Share by Region (2026-2031)
Table 13. Hematologic Malignancies Detection Market Trends
Table 14. Hematologic Malignancies Detection Market Drivers
Table 15. Hematologic Malignancies Detection Market Challenges
Table 16. Hematologic Malignancies Detection Market Restraints
Table 17. Global Hematologic Malignancies Detection Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Hematologic Malignancies Detection Market Share by Players (2020-2025)
Table 19. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)
Table 20. Ranking of Global Top Hematologic Malignancies Detection Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Hematologic Malignancies Detection Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Hematologic Malignancies Detection, Headquarters and Area Served
Table 23. Global Key Players of Hematologic Malignancies Detection, Product and Application
Table 24. Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematologic Malignancies Detection Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Hematologic Malignancies Detection Revenue Market Share by Type (2020-2025)
Table 28. Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Hematologic Malignancies Detection Revenue Market Share by Type (2026-2031)
Table 30. Global Hematologic Malignancies Detection Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Hematologic Malignancies Detection Revenue Market Share by Application (2020-2025)
Table 32. Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Hematologic Malignancies Detection Revenue Market Share by Application (2026-2031)
Table 34. North America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Hematologic Malignancies Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 49. ArcherDx Company Details
Table 50. ArcherDx Business Overview
Table 51. ArcherDx Hematologic Malignancies Detection Product
Table 52. ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 53. ArcherDx Recent Development
Table 54. Bio-Rad Laboratories Company Details
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Hematologic Malignancies Detection Product
Table 57. Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 58. Bio-Rad Laboratories Recent Development
Table 59. sysmex Company Details
Table 60. sysmex Business Overview
Table 61. sysmex Hematologic Malignancies Detection Product
Table 62. sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 63. sysmex Recent Development
Table 64. Invitae Company Details
Table 65. Invitae Business Overview
Table 66. Invitae Hematologic Malignancies Detection Product
Table 67. Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 68. Invitae Recent Development
Table 69. NeoGenomics Laboratories Company Details
Table 70. NeoGenomics Laboratories Business Overview
Table 71. NeoGenomics Laboratories Hematologic Malignancies Detection Product
Table 72. NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 73. NeoGenomics Laboratories Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Hematologic Malignancies Detection Product
Table 77. Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Cancer Genetics Company Details
Table 80. Cancer Genetics Business Overview
Table 81. Cancer Genetics Hematologic Malignancies Detection Product
Table 82. Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 83. Cancer Genetics Recent Development
Table 84. Adaptive Biotechnologies Corporation Company Details
Table 85. Adaptive Biotechnologies Corporation Business Overview
Table 86. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product
Table 87. Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 88. Adaptive Biotechnologies Corporation Recent Development
Table 89. Asuragen Company Details
Table 90. Asuragen Business Overview
Table 91. Asuragen Hematologic Malignancies Detection Product
Table 92. Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 93. Asuragen Recent Development
Table 94. Invivoscribe Company Details
Table 95. Invivoscribe Business Overview
Table 96. Invivoscribe Hematologic Malignancies Detection Product
Table 97. Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 98. Invivoscribe Recent Development
Table 99. Nanjing Shihejiyin Technology Company Details
Table 100. Nanjing Shihejiyin Technology Business Overview
Table 101. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product
Table 102. Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 103. Nanjing Shihejiyin Technology Recent Development
Table 104. Annaroad Gene Technology Company Details
Table 105. Annaroad Gene Technology Business Overview
Table 106. Annaroad Gene Technology Hematologic Malignancies Detection Product
Table 107. Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 108. Annaroad Gene Technology Recent Development
Table 109. BGI Genomics Company Details
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Hematologic Malignancies Detection Product
Table 112. BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Hematologic Malignancies Detection Picture
Figure 2. Global Hematologic Malignancies Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hematologic Malignancies Detection Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction Features
Figure 5. Immunochemistry Features
Figure 6. Next Generation Sequencing Features
Figure 7. Fluorescence in Situ Hybridization Features
Figure 8. Others Features
Figure 9. Global Hematologic Malignancies Detection Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Hematologic Malignancies Detection Market Share by Application: 2024 VS 2031
Figure 11. Multiple Myeloma Case Studies
Figure 12. Myelodysplastic Syndrome Case Studies
Figure 13. Leukemia Case Studies
Figure 14. Myeloproliferative Neoplasms Case Studies
Figure 15. Lymphoma Case Studies
Figure 16. Others Case Studies
Figure 17. Hematologic Malignancies Detection Report Years Considered
Figure 18. Global Hematologic Malignancies Detection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Hematologic Malignancies Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Hematologic Malignancies Detection Market Share by Region: 2024 VS 2031
Figure 21. Global Hematologic Malignancies Detection Market Share by Players in 2024
Figure 22. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Hematologic Malignancies Detection Revenue in 2024
Figure 24. North America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 26. United States Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 30. Germany Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Hematologic Malignancies Detection Market Share by Region (2020-2031)
Figure 38. China Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 46. Mexico Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 50. Turkey Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. ArcherDx Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 55. sysmex Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 56. Invitae Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 57. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 58. Abbott Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 59. Cancer Genetics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 60. Adaptive Biotechnologies Corporation Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 61. Asuragen Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 62. Invivoscribe Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 63. Nanjing Shihejiyin Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 64. Annaroad Gene Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 65. BGI Genomics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Hematologic Malignancies Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Immunochemistry
Table 4. Key Players of Next Generation Sequencing
Table 5. Key Players of Fluorescence in Situ Hybridization
Table 6. Key Players of Others
Table 7. Global Hematologic Malignancies Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Hematologic Malignancies Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Hematologic Malignancies Detection Market Share by Region (2020-2025)
Table 11. Global Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Hematologic Malignancies Detection Market Share by Region (2026-2031)
Table 13. Hematologic Malignancies Detection Market Trends
Table 14. Hematologic Malignancies Detection Market Drivers
Table 15. Hematologic Malignancies Detection Market Challenges
Table 16. Hematologic Malignancies Detection Market Restraints
Table 17. Global Hematologic Malignancies Detection Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Hematologic Malignancies Detection Market Share by Players (2020-2025)
Table 19. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)
Table 20. Ranking of Global Top Hematologic Malignancies Detection Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Hematologic Malignancies Detection Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Hematologic Malignancies Detection, Headquarters and Area Served
Table 23. Global Key Players of Hematologic Malignancies Detection, Product and Application
Table 24. Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematologic Malignancies Detection Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Hematologic Malignancies Detection Revenue Market Share by Type (2020-2025)
Table 28. Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Hematologic Malignancies Detection Revenue Market Share by Type (2026-2031)
Table 30. Global Hematologic Malignancies Detection Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Hematologic Malignancies Detection Revenue Market Share by Application (2020-2025)
Table 32. Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Hematologic Malignancies Detection Revenue Market Share by Application (2026-2031)
Table 34. North America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Hematologic Malignancies Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)
Table 49. ArcherDx Company Details
Table 50. ArcherDx Business Overview
Table 51. ArcherDx Hematologic Malignancies Detection Product
Table 52. ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 53. ArcherDx Recent Development
Table 54. Bio-Rad Laboratories Company Details
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Hematologic Malignancies Detection Product
Table 57. Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 58. Bio-Rad Laboratories Recent Development
Table 59. sysmex Company Details
Table 60. sysmex Business Overview
Table 61. sysmex Hematologic Malignancies Detection Product
Table 62. sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 63. sysmex Recent Development
Table 64. Invitae Company Details
Table 65. Invitae Business Overview
Table 66. Invitae Hematologic Malignancies Detection Product
Table 67. Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 68. Invitae Recent Development
Table 69. NeoGenomics Laboratories Company Details
Table 70. NeoGenomics Laboratories Business Overview
Table 71. NeoGenomics Laboratories Hematologic Malignancies Detection Product
Table 72. NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 73. NeoGenomics Laboratories Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Hematologic Malignancies Detection Product
Table 77. Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Cancer Genetics Company Details
Table 80. Cancer Genetics Business Overview
Table 81. Cancer Genetics Hematologic Malignancies Detection Product
Table 82. Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 83. Cancer Genetics Recent Development
Table 84. Adaptive Biotechnologies Corporation Company Details
Table 85. Adaptive Biotechnologies Corporation Business Overview
Table 86. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product
Table 87. Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 88. Adaptive Biotechnologies Corporation Recent Development
Table 89. Asuragen Company Details
Table 90. Asuragen Business Overview
Table 91. Asuragen Hematologic Malignancies Detection Product
Table 92. Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 93. Asuragen Recent Development
Table 94. Invivoscribe Company Details
Table 95. Invivoscribe Business Overview
Table 96. Invivoscribe Hematologic Malignancies Detection Product
Table 97. Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 98. Invivoscribe Recent Development
Table 99. Nanjing Shihejiyin Technology Company Details
Table 100. Nanjing Shihejiyin Technology Business Overview
Table 101. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product
Table 102. Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 103. Nanjing Shihejiyin Technology Recent Development
Table 104. Annaroad Gene Technology Company Details
Table 105. Annaroad Gene Technology Business Overview
Table 106. Annaroad Gene Technology Hematologic Malignancies Detection Product
Table 107. Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 108. Annaroad Gene Technology Recent Development
Table 109. BGI Genomics Company Details
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Hematologic Malignancies Detection Product
Table 112. BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Hematologic Malignancies Detection Picture
Figure 2. Global Hematologic Malignancies Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hematologic Malignancies Detection Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction Features
Figure 5. Immunochemistry Features
Figure 6. Next Generation Sequencing Features
Figure 7. Fluorescence in Situ Hybridization Features
Figure 8. Others Features
Figure 9. Global Hematologic Malignancies Detection Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Hematologic Malignancies Detection Market Share by Application: 2024 VS 2031
Figure 11. Multiple Myeloma Case Studies
Figure 12. Myelodysplastic Syndrome Case Studies
Figure 13. Leukemia Case Studies
Figure 14. Myeloproliferative Neoplasms Case Studies
Figure 15. Lymphoma Case Studies
Figure 16. Others Case Studies
Figure 17. Hematologic Malignancies Detection Report Years Considered
Figure 18. Global Hematologic Malignancies Detection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Hematologic Malignancies Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Hematologic Malignancies Detection Market Share by Region: 2024 VS 2031
Figure 21. Global Hematologic Malignancies Detection Market Share by Players in 2024
Figure 22. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Hematologic Malignancies Detection Revenue in 2024
Figure 24. North America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 26. United States Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 30. Germany Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Hematologic Malignancies Detection Market Share by Region (2020-2031)
Figure 38. China Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 46. Mexico Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Hematologic Malignancies Detection Market Share by Country (2020-2031)
Figure 50. Turkey Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. ArcherDx Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 55. sysmex Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 56. Invitae Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 57. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 58. Abbott Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 59. Cancer Genetics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 60. Adaptive Biotechnologies Corporation Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 61. Asuragen Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 62. Invivoscribe Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 63. Nanjing Shihejiyin Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 64. Annaroad Gene Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 65. BGI Genomics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232